I found CCR5 when doing research on Merck's Keytud
Post# of 148175
Started to read papers on CCR5 and “discovered” the HIV indication. Being familiar with SAE’s of all cancer drugs I could not believe that it did not have secondary effects.
Several papers afterwards I was convinced that this was the case (no SEAs). The day that happened I was converted and started buying CYDY shares. The more I read the more I bought.
Unfortunately, that was many years back and my entry price was relatively high. I discharged my money management rules and keep on buying all the way to the 30’s. My last purchase was last Friday as I believe that we are way undervalued.
The rest is history Still on the making.